Venture Fund
Prof. Francis Waldvogel
Chairman
Former Chairman of the Board of the Swiss Federal Institute of Technology, University of Geneva, Switzerland
Prof. Michel Aguet
Director of the Swiss Institute for Experimental Cancer Research (ISREC) and the “Molecular Oncology” National Center for Competence in Research, School of Life Sciences at EPFL, Epalinges/Lausanne, Switzerland
Prof. Jeffrey A. Hubbell
Professor and Director of the Institute of Bioengineering, and Professor of the Institute of Chemical Sciences and Engineering, EPFL
Prof. Jean-Marie Lehn
Nobel Prize Winner for Chemistry, Collège de France, Paris, Université Louis Pasteur, Strasbourg, France
Prof. Christoph A. Meier
Chief, Department of Internal Medicine and Specialties, Triemli Hospital Zurich, and Associate Professor, Medical Faculty, University of Geneva
Dr. Trevor Mundel
Global Head of Development, Novartis Pharma
Dr. Raj Parekh
General Partner at Advent Venture Partners, London, UK
Jonathan Symonds
Chief Financial Officer (CFO) of Novartis and member of the Executive Committee of Novartis (ECN)
